moperone
This page covers all moperone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(4) dopamine receptor, D(2) dopamine receptor, D(3) dopamine receptor.
Targets
D(4) dopamine receptor, D(2) dopamine receptor, D(3) dopamine receptor
Phase 2 pipeline (1)
- Meperon · Other
Moperone works by blocking the D(3) dopamine receptor, which is involved in regulating the brain's reward and motivation systems.
Patent intelligence
- moperone patent landscape — aggregated cliff calendar, attackable patents, originator estates